nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—FDX1—nephron tubule—kidney cancer	0.0184	0.133	CbGeAlD
Mitotane—FDX1—renal system—kidney cancer	0.0167	0.121	CbGeAlD
Mitotane—FDX1—kidney—kidney cancer	0.0161	0.117	CbGeAlD
Mitotane—FDX1—cortex of kidney—kidney cancer	0.0157	0.114	CbGeAlD
Mitotane—FDX1—gonad—kidney cancer	0.015	0.108	CbGeAlD
Mitotane—FDX1—cardiac atrium—kidney cancer	0.015	0.108	CbGeAlD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—ANXA4—kidney cancer	0.0103	0.047	CbGpPWpGaD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.00864	0.0393	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—ACY1—kidney cancer	0.00837	0.0381	CbGpPWpGaD
Mitotane—SERPINA6—nephron tubule—kidney cancer	0.00794	0.0575	CbGeAlD
Mitotane—SERPINA6—renal system—kidney cancer	0.00722	0.0523	CbGeAlD
Mitotane—SERPINA6—kidney—kidney cancer	0.00698	0.0505	CbGeAlD
Mitotane—CYP11A1—gonad—kidney cancer	0.00681	0.0493	CbGeAlD
Mitotane—SERPINA6—cortex of kidney—kidney cancer	0.0068	0.0492	CbGeAlD
Mitotane—FDX1—Endogenous sterols—POMC—kidney cancer	0.00607	0.0276	CbGpPWpGaD
Mitotane—SHBG—gonad—kidney cancer	0.00545	0.0395	CbGeAlD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—ANXA2—kidney cancer	0.00542	0.0247	CbGpPWpGaD
Mitotane—CYP11B1—Glucocorticoid biosynthesis—POMC—kidney cancer	0.00503	0.0229	CbGpPWpGaD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.00476	0.0217	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—ALDH1A1—kidney cancer	0.00459	0.0209	CbGpPWpGaD
Mitotane—FDX1—Metabolism of steroid hormones and vitamin D—POMC—kidney cancer	0.00455	0.0207	CbGpPWpGaD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.00378	0.0172	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—FOSL2—kidney cancer	0.00373	0.017	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—FOSL2—kidney cancer	0.00319	0.0145	CbGpPWpGaD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—PTGS1—kidney cancer	0.00311	0.0142	CbGpPWpGaD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.00308	0.014	CbGpPWpGaD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.00307	0.014	CbGpPWpGaD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—ANXA1—kidney cancer	0.00305	0.0139	CbGpPWpGaD
Mitotane—SHBG—Nongenotropic Androgen signaling—RAF1—kidney cancer	0.00299	0.0136	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—ACY1—kidney cancer	0.00298	0.0136	CbGpPWpGaD
Mitotane—FDX1—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.00282	0.0128	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—GSTT1—kidney cancer	0.0027	0.0123	CbGpPWpGaD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.00263	0.012	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—ACY1—kidney cancer	0.00255	0.0116	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—PTGS1—kidney cancer	0.00253	0.0115	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—FOSL1—kidney cancer	0.00249	0.0113	CbGpPWpGaD
Mitotane—FDX1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.00229	0.0104	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.00223	0.0101	CbGpPWpGaD
Mitotane—CYP11B1—Endogenous sterols—POMC—kidney cancer	0.00216	0.00985	CbGpPWpGaD
Mitotane—SHBG—Nongenotropic Androgen signaling—MAPK3—kidney cancer	0.00215	0.00981	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—FOSL1—kidney cancer	0.00213	0.00969	CbGpPWpGaD
Mitotane—SHBG—Nongenotropic Androgen signaling—MAPK1—kidney cancer	0.00205	0.00933	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—JUND—kidney cancer	0.00192	0.00875	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—GSTP1—kidney cancer	0.00187	0.00851	CbGpPWpGaD
Mitotane—CYP11A1—Endogenous sterols—POMC—kidney cancer	0.00185	0.00842	CbGpPWpGaD
Mitotane—SHBG—Nongenotropic Androgen signaling—PIK3CA—kidney cancer	0.00178	0.0081	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—GSTM1—kidney cancer	0.00172	0.00782	CbGpPWpGaD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.00169	0.00772	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—JUND—kidney cancer	0.00164	0.00749	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—ALDH1A1—kidney cancer	0.00163	0.00744	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—CYP1A1—kidney cancer	0.00163	0.00741	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of steroid hormones and vitamin D—POMC—kidney cancer	0.00162	0.00738	CbGpPWpGaD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.00145	0.0066	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ACY1—kidney cancer	0.00143	0.00652	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—ALDH1A1—kidney cancer	0.0014	0.00637	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of steroid hormones and vitamin D—POMC—kidney cancer	0.00139	0.00631	CbGpPWpGaD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.00135	0.00613	CbGpPWpGaD
Mitotane—CYP11B1—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.00133	0.00605	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—JUNB—kidney cancer	0.00131	0.00595	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.00122	0.00556	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PDHB—kidney cancer	0.00122	0.00554	CbGpPWpGaD
Mitotane—FDX1—Biological oxidations—POMC—kidney cancer	0.00121	0.00553	CbGpPWpGaD
Mitotane—CYP11A1—Prostaglandin Synthesis and Regulation—PTGS2—kidney cancer	0.00119	0.00543	CbGpPWpGaD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.00115	0.00525	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CCBL1—kidney cancer	0.00114	0.00521	CbGpPWpGaD
Mitotane—CYP11A1—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.00114	0.00518	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—JUNB—kidney cancer	0.00112	0.00509	CbGpPWpGaD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.00109	0.00497	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.00104	0.00471	CbGpPWpGaD
Mitotane—CYP11B1—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.001	0.00457	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PPAT—kidney cancer	0.000993	0.00452	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GLIPR1—kidney cancer	0.000993	0.00452	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.00098	0.00446	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.00097	0.00442	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—GSTT1—kidney cancer	0.000961	0.00437	CbGpPWpGaD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000934	0.00425	CbGpPWpGaD
Mitotane—FDX1—Metabolism—APRT—kidney cancer	0.000923	0.0042	CbGpPWpGaD
Mitotane—FDX1—Metabolism—FH—kidney cancer	0.000923	0.0042	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000902	0.00411	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—PTGS1—kidney cancer	0.0009	0.0041	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GPC3—kidney cancer	0.000868	0.00395	CbGpPWpGaD
Mitotane—CYP11A1—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000859	0.00391	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CA2—kidney cancer	0.000844	0.00384	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ALAD—kidney cancer	0.000823	0.00375	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—GSTT1—kidney cancer	0.000822	0.00374	CbGpPWpGaD
Mitotane—CYP11B1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000814	0.00371	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ST3GAL2—kidney cancer	0.000803	0.00366	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000794	0.00362	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ALDH1A1—kidney cancer	0.000785	0.00357	CbGpPWpGaD
Mitotane—CYP11A1—Biological oxidations—PTGS1—kidney cancer	0.00077	0.00351	CbGpPWpGaD
Mitotane—FDX1—Metabolism—SLC5A3—kidney cancer	0.000752	0.00343	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PGK1—kidney cancer	0.000752	0.00343	CbGpPWpGaD
Mitotane—FDX1—Metabolism—LDHB—kidney cancer	0.000738	0.00336	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—POMC—kidney cancer	0.000713	0.00325	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—BRAF—kidney cancer	0.000705	0.00321	CbGpPWpGaD
Mitotane—CYP11A1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000697	0.00317	CbGpPWpGaD
Mitotane—Thrombocytopenia—Dactinomycin—kidney cancer	0.00068	0.00106	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000679	0.00309	CbGpPWpGaD
Mitotane—Dyspepsia—Sorafenib—kidney cancer	0.000671	0.00105	CcSEcCtD
Mitotane—Body temperature increased—Erlotinib—kidney cancer	0.00067	0.00104	CcSEcCtD
Mitotane—Visual impairment—Paclitaxel—kidney cancer	0.000669	0.00104	CcSEcCtD
Mitotane—Anaemia—Gemcitabine—kidney cancer	0.000667	0.00104	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—GSTP1—kidney cancer	0.000666	0.00303	CbGpPWpGaD
Mitotane—Neutropenia—Capecitabine—kidney cancer	0.000665	0.00104	CcSEcCtD
Mitotane—Decreased appetite—Sorafenib—kidney cancer	0.000663	0.00103	CcSEcCtD
Mitotane—Anorexia—Dactinomycin—kidney cancer	0.000662	0.00103	CcSEcCtD
Mitotane—Nausea—Pazopanib—kidney cancer	0.000661	0.00103	CcSEcCtD
Mitotane—Neoplasm—Doxorubicin—kidney cancer	0.000661	0.00103	CcSEcCtD
Mitotane—Paraesthesia—Sunitinib—kidney cancer	0.000659	0.00103	CcSEcCtD
Mitotane—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000659	0.00103	CcSEcCtD
Mitotane—Hypertension—Vincristine—kidney cancer	0.000657	0.00102	CcSEcCtD
Mitotane—CYP11B1—Metapathway biotransformation—GSTP1—kidney cancer	0.000657	0.00299	CbGpPWpGaD
Mitotane—Pain—Sorafenib—kidney cancer	0.000652	0.00102	CcSEcCtD
Mitotane—Hypersensitivity—Vinblastine—kidney cancer	0.00065	0.00101	CcSEcCtD
Mitotane—Eye disorder—Paclitaxel—kidney cancer	0.000649	0.00101	CcSEcCtD
Mitotane—Hypersensitivity—Everolimus—kidney cancer	0.000647	0.00101	CcSEcCtD
Mitotane—Dyspepsia—Sunitinib—kidney cancer	0.000646	0.00101	CcSEcCtD
Mitotane—Flushing—Paclitaxel—kidney cancer	0.000644	0.001	CcSEcCtD
Mitotane—FDX1—Metabolism—CA9—kidney cancer	0.00064	0.00291	CbGpPWpGaD
Mitotane—Decreased appetite—Sunitinib—kidney cancer	0.000638	0.000993	CcSEcCtD
Mitotane—Infestation NOS—Capecitabine—kidney cancer	0.000634	0.000988	CcSEcCtD
Mitotane—Infestation—Capecitabine—kidney cancer	0.000634	0.000988	CcSEcCtD
Mitotane—Mental disability—Doxorubicin—kidney cancer	0.000634	0.000988	CcSEcCtD
Mitotane—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000634	0.000987	CcSEcCtD
Mitotane—Asthenia—Vinblastine—kidney cancer	0.000633	0.000985	CcSEcCtD
Mitotane—Asthenia—Everolimus—kidney cancer	0.00063	0.000982	CcSEcCtD
Mitotane—Angiopathy—Paclitaxel—kidney cancer	0.00063	0.00098	CcSEcCtD
Mitotane—Pain—Sunitinib—kidney cancer	0.000628	0.000977	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000625	0.00285	CbGpPWpGaD
Mitotane—Hypertension—Gemcitabine—kidney cancer	0.000623	0.00097	CcSEcCtD
Mitotane—Infection—Vincristine—kidney cancer	0.000617	0.00096	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—GSTM1—kidney cancer	0.000612	0.00279	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—POMC—kidney cancer	0.00061	0.00278	CbGpPWpGaD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.00061	0.00095	CcSEcCtD
Mitotane—Nervous system disorder—Vincristine—kidney cancer	0.000609	0.000948	CcSEcCtD
Mitotane—Asthenia—Erlotinib—kidney cancer	0.000608	0.000947	CcSEcCtD
Mitotane—Mental disorder—Paclitaxel—kidney cancer	0.000608	0.000947	CcSEcCtD
Mitotane—Thrombocytopenia—Vincristine—kidney cancer	0.000608	0.000946	CcSEcCtD
Mitotane—Haematuria—Capecitabine—kidney cancer	0.000605	0.000942	CcSEcCtD
Mitotane—Malnutrition—Paclitaxel—kidney cancer	0.000604	0.000941	CcSEcCtD
Mitotane—Decreased appetite—Dactinomycin—kidney cancer	0.000604	0.00094	CcSEcCtD
Mitotane—Diarrhoea—Vinblastine—kidney cancer	0.000604	0.00094	CcSEcCtD
Mitotane—CYP11B1—Metapathway biotransformation—GSTM1—kidney cancer	0.000603	0.00275	CbGpPWpGaD
Mitotane—Body temperature increased—Sorafenib—kidney cancer	0.000603	0.000939	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—BRAF—kidney cancer	0.000603	0.00274	CbGpPWpGaD
Mitotane—Diarrhoea—Everolimus—kidney cancer	0.000601	0.000936	CcSEcCtD
Mitotane—Hepatobiliary disease—Capecitabine—kidney cancer	0.0006	0.000934	CcSEcCtD
Mitotane—Pain—Dactinomycin—kidney cancer	0.000594	0.000925	CcSEcCtD
Mitotane—Anorexia—Vincristine—kidney cancer	0.000592	0.000921	CcSEcCtD
Mitotane—Dysgeusia—Paclitaxel—kidney cancer	0.000592	0.000921	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—RAF1—kidney cancer	0.000588	0.00268	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—RELA—kidney cancer	0.000586	0.00267	CbGpPWpGaD
Mitotane—Infection—Gemcitabine—kidney cancer	0.000585	0.000911	CcSEcCtD
Mitotane—Dizziness—Vinblastine—kidney cancer	0.000583	0.000908	CcSEcCtD
Mitotane—Dizziness—Everolimus—kidney cancer	0.000581	0.000905	CcSEcCtD
Mitotane—Body temperature increased—Sunitinib—kidney cancer	0.00058	0.000903	CcSEcCtD
Mitotane—Diarrhoea—Erlotinib—kidney cancer	0.00058	0.000903	CcSEcCtD
Mitotane—Hypotension—Vincristine—kidney cancer	0.00058	0.000903	CcSEcCtD
Mitotane—CYP11B1—Biological oxidations—CYP1A1—kidney cancer	0.00058	0.00264	CbGpPWpGaD
Mitotane—Nervous system disorder—Gemcitabine—kidney cancer	0.000578	0.000899	CcSEcCtD
Mitotane—Thrombocytopenia—Gemcitabine—kidney cancer	0.000577	0.000898	CcSEcCtD
Mitotane—Feeling abnormal—Dactinomycin—kidney cancer	0.000573	0.000892	CcSEcCtD
Mitotane—CYP11B1—Metapathway biotransformation—CYP1A1—kidney cancer	0.000572	0.0026	CbGpPWpGaD
Mitotane—Skin disorder—Gemcitabine—kidney cancer	0.000572	0.000891	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—GSTP1—kidney cancer	0.00057	0.00259	CbGpPWpGaD
Mitotane—Hepatitis—Capecitabine—kidney cancer	0.00057	0.000887	CcSEcCtD
Mitotane—Vision blurred—Paclitaxel—kidney cancer	0.000569	0.000887	CcSEcCtD
Mitotane—Tremor—Paclitaxel—kidney cancer	0.000566	0.000881	CcSEcCtD
Mitotane—Urinary tract disorder—Capecitabine—kidney cancer	0.000562	0.000876	CcSEcCtD
Mitotane—Hypersensitivity—Sorafenib—kidney cancer	0.000562	0.000875	CcSEcCtD
Mitotane—CYP11A1—Metapathway biotransformation—GSTP1—kidney cancer	0.000562	0.00256	CbGpPWpGaD
Mitotane—Anorexia—Gemcitabine—kidney cancer	0.000561	0.000874	CcSEcCtD
Mitotane—Vomiting—Vinblastine—kidney cancer	0.000561	0.000873	CcSEcCtD
Mitotane—Dizziness—Erlotinib—kidney cancer	0.000561	0.000873	CcSEcCtD
Mitotane—Connective tissue disorder—Capecitabine—kidney cancer	0.00056	0.000871	CcSEcCtD
Mitotane—Vomiting—Everolimus—kidney cancer	0.000559	0.00087	CcSEcCtD
Mitotane—Anaemia—Paclitaxel—kidney cancer	0.000558	0.000869	CcSEcCtD
Mitotane—Urethral disorder—Capecitabine—kidney cancer	0.000558	0.000869	CcSEcCtD
Mitotane—Paraesthesia—Vincristine—kidney cancer	0.000557	0.000868	CcSEcCtD
Mitotane—Rash—Everolimus—kidney cancer	0.000554	0.000863	CcSEcCtD
Mitotane—Dermatitis—Everolimus—kidney cancer	0.000554	0.000862	CcSEcCtD
Mitotane—Headache—Vinblastine—kidney cancer	0.000553	0.00086	CcSEcCtD
Mitotane—Headache—Everolimus—kidney cancer	0.00055	0.000857	CcSEcCtD
Mitotane—Hypotension—Gemcitabine—kidney cancer	0.00055	0.000857	CcSEcCtD
Mitotane—Body temperature increased—Dactinomycin—kidney cancer	0.000549	0.000855	CcSEcCtD
Mitotane—Visual impairment—Capecitabine—kidney cancer	0.000549	0.000855	CcSEcCtD
Mitotane—Asthenia—Sorafenib—kidney cancer	0.000547	0.000852	CcSEcCtD
Mitotane—FDX1—Metabolism—CRABP1—kidney cancer	0.000544	0.00248	CbGpPWpGaD
Mitotane—Vertigo—Paclitaxel—kidney cancer	0.000543	0.000845	CcSEcCtD
Mitotane—Lethargy—Doxorubicin—kidney cancer	0.000542	0.000843	CcSEcCtD
Mitotane—Hypersensitivity—Sunitinib—kidney cancer	0.000541	0.000842	CcSEcCtD
Mitotane—Decreased appetite—Vincristine—kidney cancer	0.00054	0.00084	CcSEcCtD
Mitotane—Vomiting—Erlotinib—kidney cancer	0.000539	0.000839	CcSEcCtD
Mitotane—Gastrointestinal disorder—Vincristine—kidney cancer	0.000536	0.000834	CcSEcCtD
Mitotane—Rash—Erlotinib—kidney cancer	0.000535	0.000832	CcSEcCtD
Mitotane—Dermatitis—Erlotinib—kidney cancer	0.000534	0.000832	CcSEcCtD
Mitotane—Eye disorder—Capecitabine—kidney cancer	0.000532	0.000829	CcSEcCtD
Mitotane—Headache—Erlotinib—kidney cancer	0.000531	0.000827	CcSEcCtD
Mitotane—Pain—Vincristine—kidney cancer	0.000531	0.000827	CcSEcCtD
Mitotane—Osteoarthritis—Doxorubicin—kidney cancer	0.000531	0.000826	CcSEcCtD
Mitotane—Diplopia—Doxorubicin—kidney cancer	0.000531	0.000826	CcSEcCtD
Mitotane—Paraesthesia—Gemcitabine—kidney cancer	0.000529	0.000823	CcSEcCtD
Mitotane—Flushing—Capecitabine—kidney cancer	0.000529	0.000823	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—IL2—kidney cancer	0.000527	0.0024	CbGpPWpGaD
Mitotane—Asthenia—Sunitinib—kidney cancer	0.000527	0.00082	CcSEcCtD
Mitotane—Nausea—Vinblastine—kidney cancer	0.000524	0.000816	CcSEcCtD
Mitotane—Somnolence—Gemcitabine—kidney cancer	0.000524	0.000815	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—GSTM1—kidney cancer	0.000523	0.00238	CbGpPWpGaD
Mitotane—Nausea—Everolimus—kidney cancer	0.000522	0.000813	CcSEcCtD
Mitotane—Diarrhoea—Sorafenib—kidney cancer	0.000522	0.000813	CcSEcCtD
Mitotane—Hypertension—Paclitaxel—kidney cancer	0.000522	0.000812	CcSEcCtD
Mitotane—Angiopathy—Capecitabine—kidney cancer	0.000517	0.000805	CcSEcCtD
Mitotane—CYP11A1—Metapathway biotransformation—GSTM1—kidney cancer	0.000516	0.00235	CbGpPWpGaD
Mitotane—Decreased appetite—Gemcitabine—kidney cancer	0.000512	0.000797	CcSEcCtD
Mitotane—Hypersensitivity—Dactinomycin—kidney cancer	0.000512	0.000797	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000511	0.000795	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ACY1—kidney cancer	0.00051	0.00232	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—CTNNB1—kidney cancer	0.000509	0.00232	CbGpPWpGaD
Mitotane—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000508	0.000792	CcSEcCtD
Mitotane—FDX1—Metabolism—ITPR2—kidney cancer	0.000506	0.0023	CbGpPWpGaD
Mitotane—Dizziness—Sorafenib—kidney cancer	0.000504	0.000785	CcSEcCtD
Mitotane—Pain—Gemcitabine—kidney cancer	0.000504	0.000784	CcSEcCtD
Mitotane—Nausea—Erlotinib—kidney cancer	0.000504	0.000784	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—RAF1—kidney cancer	0.000503	0.00229	CbGpPWpGaD
Mitotane—Diarrhoea—Sunitinib—kidney cancer	0.000502	0.000782	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—RELA—kidney cancer	0.000501	0.00228	CbGpPWpGaD
Mitotane—Ataxia—Doxorubicin—kidney cancer	0.000499	0.000777	CcSEcCtD
Mitotane—Mental disorder—Capecitabine—kidney cancer	0.000499	0.000777	CcSEcCtD
Mitotane—Asthenia—Dactinomycin—kidney cancer	0.000499	0.000776	CcSEcCtD
Mitotane—Confusional state—Paclitaxel—kidney cancer	0.000497	0.000774	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—CYP1A1—kidney cancer	0.000496	0.00226	CbGpPWpGaD
Mitotane—Malnutrition—Capecitabine—kidney cancer	0.000496	0.000772	CcSEcCtD
Mitotane—Body temperature increased—Vincristine—kidney cancer	0.000491	0.000764	CcSEcCtD
Mitotane—Infection—Paclitaxel—kidney cancer	0.00049	0.000763	CcSEcCtD
Mitotane—CYP11A1—Metapathway biotransformation—CYP1A1—kidney cancer	0.000489	0.00223	CbGpPWpGaD
Mitotane—Dysgeusia—Capecitabine—kidney cancer	0.000486	0.000756	CcSEcCtD
Mitotane—Dizziness—Sunitinib—kidney cancer	0.000485	0.000756	CcSEcCtD
Mitotane—Feeling abnormal—Gemcitabine—kidney cancer	0.000485	0.000756	CcSEcCtD
Mitotane—Shock—Paclitaxel—kidney cancer	0.000485	0.000755	CcSEcCtD
Mitotane—Vomiting—Sorafenib—kidney cancer	0.000485	0.000755	CcSEcCtD
Mitotane—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000485	0.000755	CcSEcCtD
Mitotane—Nervous system disorder—Paclitaxel—kidney cancer	0.000484	0.000753	CcSEcCtD
Mitotane—Thrombocytopenia—Paclitaxel—kidney cancer	0.000483	0.000752	CcSEcCtD
Mitotane—Rash—Sorafenib—kidney cancer	0.000481	0.000749	CcSEcCtD
Mitotane—Dermatitis—Sorafenib—kidney cancer	0.00048	0.000748	CcSEcCtD
Mitotane—Breast disorder—Doxorubicin—kidney cancer	0.00048	0.000747	CcSEcCtD
Mitotane—Skin disorder—Paclitaxel—kidney cancer	0.000479	0.000746	CcSEcCtD
Mitotane—Headache—Sorafenib—kidney cancer	0.000478	0.000744	CcSEcCtD
Mitotane—Diarrhoea—Dactinomycin—kidney cancer	0.000475	0.00074	CcSEcCtD
Mitotane—Anorexia—Paclitaxel—kidney cancer	0.00047	0.000732	CcSEcCtD
Mitotane—Muscular weakness—Doxorubicin—kidney cancer	0.000468	0.000729	CcSEcCtD
Mitotane—Vision blurred—Capecitabine—kidney cancer	0.000467	0.000728	CcSEcCtD
Mitotane—Vomiting—Sunitinib—kidney cancer	0.000467	0.000727	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000466	0.00212	CbGpPWpGaD
Mitotane—Body temperature increased—Gemcitabine—kidney cancer	0.000466	0.000725	CcSEcCtD
Mitotane—Tremor—Capecitabine—kidney cancer	0.000465	0.000723	CcSEcCtD
Mitotane—Rash—Sunitinib—kidney cancer	0.000463	0.000721	CcSEcCtD
Mitotane—Dermatitis—Sunitinib—kidney cancer	0.000462	0.00072	CcSEcCtD
Mitotane—FDX1—Metabolism—GSTT1—kidney cancer	0.000461	0.0021	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ACHE—kidney cancer	0.000461	0.0021	CbGpPWpGaD
Mitotane—Hypotension—Paclitaxel—kidney cancer	0.000461	0.000717	CcSEcCtD
Mitotane—Headache—Sunitinib—kidney cancer	0.00046	0.000716	CcSEcCtD
Mitotane—Anaemia—Capecitabine—kidney cancer	0.000458	0.000713	CcSEcCtD
Mitotane—Hypersensitivity—Vincristine—kidney cancer	0.000457	0.000712	CcSEcCtD
Mitotane—Nausea—Sorafenib—kidney cancer	0.000453	0.000705	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—IL2—kidney cancer	0.000451	0.00205	CbGpPWpGaD
Mitotane—Vertigo—Capecitabine—kidney cancer	0.000445	0.000694	CcSEcCtD
Mitotane—Asthenia—Vincristine—kidney cancer	0.000445	0.000693	CcSEcCtD
Mitotane—Paraesthesia—Paclitaxel—kidney cancer	0.000443	0.000689	CcSEcCtD
Mitotane—Vomiting—Dactinomycin—kidney cancer	0.000442	0.000688	CcSEcCtD
Mitotane—Somnolence—Paclitaxel—kidney cancer	0.000438	0.000682	CcSEcCtD
Mitotane—Rash—Dactinomycin—kidney cancer	0.000438	0.000682	CcSEcCtD
Mitotane—CYP11A1—Metabolism—ACY1—kidney cancer	0.000436	0.00199	CbGpPWpGaD
Mitotane—FDX1—Metabolism—SCARB1—kidney cancer	0.000436	0.00199	CbGpPWpGaD
Mitotane—Nausea—Sunitinib—kidney cancer	0.000436	0.000679	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—CTNNB1—kidney cancer	0.000436	0.00198	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000435	0.00198	CbGpPWpGaD
Mitotane—Dyspepsia—Paclitaxel—kidney cancer	0.000434	0.000676	CcSEcCtD
Mitotane—CYP11B1—Metabolism—PDHB—kidney cancer	0.000434	0.00198	CbGpPWpGaD
Mitotane—CYP11B1—Biological oxidations—POMC—kidney cancer	0.000432	0.00197	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PTGS1—kidney cancer	0.000432	0.00197	CbGpPWpGaD
Mitotane—Neutropenia—Doxorubicin—kidney cancer	0.000429	0.000668	CcSEcCtD
Mitotane—Decreased appetite—Paclitaxel—kidney cancer	0.000429	0.000667	CcSEcCtD
Mitotane—Hypertension—Capecitabine—kidney cancer	0.000428	0.000666	CcSEcCtD
Mitotane—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000426	0.000663	CcSEcCtD
Mitotane—Diarrhoea—Vincristine—kidney cancer	0.000425	0.000661	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—MAPK3—kidney cancer	0.000424	0.00193	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PSMD7—kidney cancer	0.000424	0.00193	CbGpPWpGaD
Mitotane—Asthenia—Gemcitabine—kidney cancer	0.000423	0.000658	CcSEcCtD
Mitotane—Pain—Paclitaxel—kidney cancer	0.000422	0.000657	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000419	0.000653	CcSEcCtD
Mitotane—Nausea—Dactinomycin—kidney cancer	0.000413	0.000643	CcSEcCtD
Mitotane—Dizziness—Vincristine—kidney cancer	0.000411	0.000639	CcSEcCtD
Mitotane—Infestation—Doxorubicin—kidney cancer	0.000409	0.000637	CcSEcCtD
Mitotane—Drowsiness—Doxorubicin—kidney cancer	0.000409	0.000637	CcSEcCtD
Mitotane—Infestation NOS—Doxorubicin—kidney cancer	0.000409	0.000637	CcSEcCtD
Mitotane—Confusional state—Capecitabine—kidney cancer	0.000408	0.000635	CcSEcCtD
Mitotane—CYP11B1—Metabolism—CCBL1—kidney cancer	0.000408	0.00186	CbGpPWpGaD
Mitotane—Feeling abnormal—Paclitaxel—kidney cancer	0.000406	0.000633	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—MAPK1—kidney cancer	0.000403	0.00184	CbGpPWpGaD
Mitotane—Diarrhoea—Gemcitabine—kidney cancer	0.000403	0.000627	CcSEcCtD
Mitotane—Infection—Capecitabine—kidney cancer	0.000402	0.000626	CcSEcCtD
Mitotane—FDX1—Metabolism—BCHE—kidney cancer	0.000402	0.00183	CbGpPWpGaD
Mitotane—Shock—Capecitabine—kidney cancer	0.000398	0.00062	CcSEcCtD
Mitotane—Nervous system disorder—Capecitabine—kidney cancer	0.000397	0.000618	CcSEcCtD
Mitotane—FDX1—Metabolism—SLC5A5—kidney cancer	0.000397	0.00181	CbGpPWpGaD
Mitotane—Thrombocytopenia—Capecitabine—kidney cancer	0.000396	0.000617	CcSEcCtD
Mitotane—Vomiting—Vincristine—kidney cancer	0.000395	0.000615	CcSEcCtD
Mitotane—Skin disorder—Capecitabine—kidney cancer	0.000393	0.000612	CcSEcCtD
Mitotane—Rash—Vincristine—kidney cancer	0.000391	0.000609	CcSEcCtD
Mitotane—Dermatitis—Vincristine—kidney cancer	0.000391	0.000609	CcSEcCtD
Mitotane—Haematuria—Doxorubicin—kidney cancer	0.00039	0.000607	CcSEcCtD
Mitotane—Body temperature increased—Paclitaxel—kidney cancer	0.00039	0.000607	CcSEcCtD
Mitotane—Headache—Vincristine—kidney cancer	0.000389	0.000606	CcSEcCtD
Mitotane—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000387	0.000602	CcSEcCtD
Mitotane—Anorexia—Capecitabine—kidney cancer	0.000386	0.000601	CcSEcCtD
Mitotane—FDX1—Metabolism—SLC2A1—kidney cancer	0.000383	0.00174	CbGpPWpGaD
Mitotane—Hypotension—Capecitabine—kidney cancer	0.000378	0.000589	CcSEcCtD
Mitotane—Vomiting—Gemcitabine—kidney cancer	0.000374	0.000583	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000372	0.00169	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.000372	0.00169	CbGpPWpGaD
Mitotane—Rash—Gemcitabine—kidney cancer	0.000371	0.000578	CcSEcCtD
Mitotane—CYP11A1—Metabolism—PDHB—kidney cancer	0.000371	0.00169	CbGpPWpGaD
Mitotane—Dermatitis—Gemcitabine—kidney cancer	0.000371	0.000578	CcSEcCtD
Mitotane—CYP11A1—Biological oxidations—POMC—kidney cancer	0.00037	0.00168	CbGpPWpGaD
Mitotane—Headache—Gemcitabine—kidney cancer	0.000369	0.000574	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000369	0.00168	CbGpPWpGaD
Mitotane—Nausea—Vincristine—kidney cancer	0.000369	0.000574	CcSEcCtD
Mitotane—Hepatitis—Doxorubicin—kidney cancer	0.000367	0.000572	CcSEcCtD
Mitotane—Paraesthesia—Capecitabine—kidney cancer	0.000363	0.000566	CcSEcCtD
Mitotane—Hypersensitivity—Paclitaxel—kidney cancer	0.000363	0.000566	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—MAPK3—kidney cancer	0.000363	0.00165	CbGpPWpGaD
Mitotane—Urinary tract disorder—Doxorubicin—kidney cancer	0.000363	0.000565	CcSEcCtD
Mitotane—Connective tissue disorder—Doxorubicin—kidney cancer	0.000361	0.000562	CcSEcCtD
Mitotane—Urethral disorder—Doxorubicin—kidney cancer	0.00036	0.00056	CcSEcCtD
Mitotane—Dyspepsia—Capecitabine—kidney cancer	0.000356	0.000555	CcSEcCtD
Mitotane—Visual impairment—Doxorubicin—kidney cancer	0.000354	0.000551	CcSEcCtD
Mitotane—Asthenia—Paclitaxel—kidney cancer	0.000354	0.000551	CcSEcCtD
Mitotane—CYP11B1—Metabolism—PPAT—kidney cancer	0.000354	0.00161	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GLIPR1—kidney cancer	0.000354	0.00161	CbGpPWpGaD
Mitotane—Decreased appetite—Capecitabine—kidney cancer	0.000352	0.000548	CcSEcCtD
Mitotane—Nausea—Gemcitabine—kidney cancer	0.00035	0.000545	CcSEcCtD
Mitotane—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000349	0.000544	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000349	0.00159	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CCBL1—kidney cancer	0.000349	0.00159	CbGpPWpGaD
Mitotane—Pain—Capecitabine—kidney cancer	0.000346	0.000539	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000346	0.00157	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—MAPK1—kidney cancer	0.000345	0.00157	CbGpPWpGaD
Mitotane—Eye disorder—Doxorubicin—kidney cancer	0.000343	0.000534	CcSEcCtD
Mitotane—Flushing—Doxorubicin—kidney cancer	0.000341	0.000531	CcSEcCtD
Mitotane—Diarrhoea—Paclitaxel—kidney cancer	0.000337	0.000525	CcSEcCtD
Mitotane—Feeling abnormal—Capecitabine—kidney cancer	0.000333	0.000519	CcSEcCtD
Mitotane—Angiopathy—Doxorubicin—kidney cancer	0.000333	0.000519	CcSEcCtD
Mitotane—CYP11B1—Metabolism—FH—kidney cancer	0.000329	0.0015	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—APRT—kidney cancer	0.000329	0.0015	CbGpPWpGaD
Mitotane—Dizziness—Paclitaxel—kidney cancer	0.000326	0.000508	CcSEcCtD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	0.000324	0.00148	CbGpPWpGaD
Mitotane—Mental disorder—Doxorubicin—kidney cancer	0.000322	0.000501	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000321	0.00146	CbGpPWpGaD
Mitotane—Body temperature increased—Capecitabine—kidney cancer	0.00032	0.000498	CcSEcCtD
Mitotane—FDX1—Metabolism—GSTP1—kidney cancer	0.00032	0.00146	CbGpPWpGaD
Mitotane—Malnutrition—Doxorubicin—kidney cancer	0.00032	0.000498	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000316	0.00144	CbGpPWpGaD
Mitotane—Vomiting—Paclitaxel—kidney cancer	0.000314	0.000488	CcSEcCtD
Mitotane—Dysgeusia—Doxorubicin—kidney cancer	0.000313	0.000487	CcSEcCtD
Mitotane—Rash—Paclitaxel—kidney cancer	0.000311	0.000484	CcSEcCtD
Mitotane—Dermatitis—Paclitaxel—kidney cancer	0.000311	0.000484	CcSEcCtD
Mitotane—CYP11B1—Metabolism—GPC3—kidney cancer	0.000309	0.00141	CbGpPWpGaD
Mitotane—Headache—Paclitaxel—kidney cancer	0.000309	0.000481	CcSEcCtD
Mitotane—CYP11A1—Metabolism—GLIPR1—kidney cancer	0.000303	0.00138	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ABCB1—kidney cancer	0.000303	0.00138	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PPAT—kidney cancer	0.000303	0.00138	CbGpPWpGaD
Mitotane—Vision blurred—Doxorubicin—kidney cancer	0.000301	0.000469	CcSEcCtD
Mitotane—CYP11B1—Metabolism—CA2—kidney cancer	0.000301	0.00137	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000299	0.00136	CbGpPWpGaD
Mitotane—Hypersensitivity—Capecitabine—kidney cancer	0.000298	0.000464	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000296	0.00135	CbGpPWpGaD
Mitotane—Anaemia—Doxorubicin—kidney cancer	0.000295	0.00046	CcSEcCtD
Mitotane—FDX1—Metabolism—GSTM1—kidney cancer	0.000294	0.00134	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ALAD—kidney cancer	0.000293	0.00133	CbGpPWpGaD
Mitotane—Nausea—Paclitaxel—kidney cancer	0.000293	0.000456	CcSEcCtD
Mitotane—Asthenia—Capecitabine—kidney cancer	0.00029	0.000452	CcSEcCtD
Mitotane—Vertigo—Doxorubicin—kidney cancer	0.000287	0.000447	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ST3GAL2—kidney cancer	0.000286	0.0013	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—FH—kidney cancer	0.000281	0.00128	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—APRT—kidney cancer	0.000281	0.00128	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ALDH1A1—kidney cancer	0.00028	0.00127	CbGpPWpGaD
Mitotane—FDX1—Metabolism—CYP1A1—kidney cancer	0.000278	0.00127	CbGpPWpGaD
Mitotane—Diarrhoea—Capecitabine—kidney cancer	0.000277	0.000431	CcSEcCtD
Mitotane—Hypertension—Doxorubicin—kidney cancer	0.000276	0.00043	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000275	0.00125	CbGpPWpGaD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.00027	0.000421	CcSEcCtD
Mitotane—CYP11B1—Metabolism—SLC5A3—kidney cancer	0.000268	0.00122	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PGK1—kidney cancer	0.000268	0.00122	CbGpPWpGaD
Mitotane—Dizziness—Capecitabine—kidney cancer	0.000268	0.000417	CcSEcCtD
Mitotane—CYP11A1—Metabolism—GPC3—kidney cancer	0.000264	0.0012	CbGpPWpGaD
Mitotane—Confusional state—Doxorubicin—kidney cancer	0.000263	0.000409	CcSEcCtD
Mitotane—CYP11B1—Metabolism—LDHB—kidney cancer	0.000263	0.0012	CbGpPWpGaD
Mitotane—Infection—Doxorubicin—kidney cancer	0.000259	0.000403	CcSEcCtD
Mitotane—Vomiting—Capecitabine—kidney cancer	0.000257	0.000401	CcSEcCtD
Mitotane—CYP11A1—Metabolism—CA2—kidney cancer	0.000257	0.00117	CbGpPWpGaD
Mitotane—Shock—Doxorubicin—kidney cancer	0.000257	0.0004	CcSEcCtD
Mitotane—Nervous system disorder—Doxorubicin—kidney cancer	0.000256	0.000398	CcSEcCtD
Mitotane—Thrombocytopenia—Doxorubicin—kidney cancer	0.000255	0.000398	CcSEcCtD
Mitotane—Rash—Capecitabine—kidney cancer	0.000255	0.000397	CcSEcCtD
Mitotane—Dermatitis—Capecitabine—kidney cancer	0.000255	0.000397	CcSEcCtD
Mitotane—Headache—Capecitabine—kidney cancer	0.000253	0.000395	CcSEcCtD
Mitotane—Skin disorder—Doxorubicin—kidney cancer	0.000253	0.000394	CcSEcCtD
Mitotane—CYP11A1—Metabolism—ALAD—kidney cancer	0.000251	0.00114	CbGpPWpGaD
Mitotane—Anorexia—Doxorubicin—kidney cancer	0.000249	0.000387	CcSEcCtD
Mitotane—CYP11A1—Metabolism—ST3GAL2—kidney cancer	0.000245	0.00111	CbGpPWpGaD
Mitotane—Hypotension—Doxorubicin—kidney cancer	0.000244	0.000379	CcSEcCtD
Mitotane—Nausea—Capecitabine—kidney cancer	0.00024	0.000374	CcSEcCtD
Mitotane—CYP11A1—Metabolism—ALDH1A1—kidney cancer	0.000239	0.00109	CbGpPWpGaD
Mitotane—Paraesthesia—Doxorubicin—kidney cancer	0.000234	0.000365	CcSEcCtD
Mitotane—Somnolence—Doxorubicin—kidney cancer	0.000232	0.000361	CcSEcCtD
Mitotane—Dyspepsia—Doxorubicin—kidney cancer	0.00023	0.000357	CcSEcCtD
Mitotane—CYP11A1—Metabolism—PGK1—kidney cancer	0.000229	0.00104	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLC5A3—kidney cancer	0.000229	0.00104	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	0.000229	0.00104	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CA9—kidney cancer	0.000228	0.00104	CbGpPWpGaD
Mitotane—Decreased appetite—Doxorubicin—kidney cancer	0.000227	0.000353	CcSEcCtD
Mitotane—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000225	0.000351	CcSEcCtD
Mitotane—CYP11A1—Metabolism—LDHB—kidney cancer	0.000225	0.00102	CbGpPWpGaD
Mitotane—Pain—Doxorubicin—kidney cancer	0.000223	0.000347	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000223	0.00101	CbGpPWpGaD
Mitotane—Feeling abnormal—Doxorubicin—kidney cancer	0.000215	0.000335	CcSEcCtD
Mitotane—FDX1—Metabolism—POMC—kidney cancer	0.000208	0.000945	CbGpPWpGaD
Mitotane—Body temperature increased—Doxorubicin—kidney cancer	0.000206	0.000321	CcSEcCtD
Mitotane—CYP11A1—Metabolism—CA9—kidney cancer	0.000195	0.000888	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CRABP1—kidney cancer	0.000194	0.000882	CbGpPWpGaD
Mitotane—Hypersensitivity—Doxorubicin—kidney cancer	0.000192	0.000299	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000191	0.000868	CbGpPWpGaD
Mitotane—Asthenia—Doxorubicin—kidney cancer	0.000187	0.000291	CcSEcCtD
Mitotane—CYP11B1—Metabolism—ITPR2—kidney cancer	0.00018	0.00082	CbGpPWpGaD
Mitotane—Diarrhoea—Doxorubicin—kidney cancer	0.000178	0.000278	CcSEcCtD
Mitotane—Dizziness—Doxorubicin—kidney cancer	0.000172	0.000269	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000166	0.000756	CbGpPWpGaD
Mitotane—Vomiting—Doxorubicin—kidney cancer	0.000166	0.000258	CcSEcCtD
Mitotane—CYP11A1—Metabolism—CRABP1—kidney cancer	0.000166	0.000755	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PTGS2—kidney cancer	0.000166	0.000754	CbGpPWpGaD
Mitotane—Rash—Doxorubicin—kidney cancer	0.000164	0.000256	CcSEcCtD
Mitotane—Dermatitis—Doxorubicin—kidney cancer	0.000164	0.000256	CcSEcCtD
Mitotane—CYP11B1—Metabolism—GSTT1—kidney cancer	0.000164	0.000748	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ACHE—kidney cancer	0.000164	0.000748	CbGpPWpGaD
Mitotane—Headache—Doxorubicin—kidney cancer	0.000163	0.000254	CcSEcCtD
Mitotane—CYP11B1—Metabolism—SCARB1—kidney cancer	0.000156	0.000708	CbGpPWpGaD
Mitotane—Nausea—Doxorubicin—kidney cancer	0.000155	0.000241	CcSEcCtD
Mitotane—CYP11A1—Metabolism—ITPR2—kidney cancer	0.000154	0.000702	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PTGS1—kidney cancer	0.000154	0.000701	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PSMD7—kidney cancer	0.000151	0.000687	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PTEN—kidney cancer	0.000144	0.000658	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—BCHE—kidney cancer	0.000143	0.000652	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	0.000142	0.000647	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SLC5A5—kidney cancer	0.000141	0.000644	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTT1—kidney cancer	0.000141	0.00064	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ACHE—kidney cancer	0.000141	0.00064	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SLC2A1—kidney cancer	0.000137	0.000622	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SCARB1—kidney cancer	0.000133	0.000606	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.000132	0.000603	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PTGS1—kidney cancer	0.000132	0.0006	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PSMD7—kidney cancer	0.000129	0.000588	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—BCHE—kidney cancer	0.000122	0.000557	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLC5A5—kidney cancer	0.000121	0.000551	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLC2A1—kidney cancer	0.000117	0.000532	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	0.000116	0.000526	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTP1—kidney cancer	0.000114	0.000518	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	0.000113	0.000516	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ABCB1—kidney cancer	0.000108	0.000491	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GSTM1—kidney cancer	0.000105	0.000476	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PIK3CA—kidney cancer	0.000102	0.000464	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—CYP1A1—kidney cancer	9.92e-05	0.000452	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.88e-05	0.00045	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTP1—kidney cancer	9.74e-05	0.000444	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ABCB1—kidney cancer	9.22e-05	0.00042	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GSTM1—kidney cancer	8.95e-05	0.000408	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—CYP1A1—kidney cancer	8.49e-05	0.000386	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.15e-05	0.000371	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—POMC—kidney cancer	7.4e-05	0.000337	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.97e-05	0.000317	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—POMC—kidney cancer	6.33e-05	0.000288	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PTGS2—kidney cancer	5.9e-05	0.000269	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PTEN—kidney cancer	5.14e-05	0.000234	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PTGS2—kidney cancer	5.05e-05	0.00023	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PTEN—kidney cancer	4.4e-05	0.0002	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—PIK3CA—kidney cancer	3.63e-05	0.000165	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—PIK3CA—kidney cancer	3.1e-05	0.000141	CbGpPWpGaD
